Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Magnesium in Controlled Bronchial Asthma
NCT06721247Phase 3Active, not recruiting
- Sponsor
- Zagazig University
- Start
- Nov 2024
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 3, randomised trial (2 arms), sponsored by Zagazig University. Primary endpoint: Improvement in the degree of asthma control at 1 year. Started Nov 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06721247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06721247.